Lasix and Haematological malignancy - a phase IV clinical study of FDA data

Summary:

Haematological malignancy is reported as a side effect among people who take Lasix (furosemide), especially for people who are female, 60+ old, also take Prednisone, and have Idiopathic thrombocytopenic purpura.

The phase IV clinical study analyzes which people have Haematological malignancy when taking Lasix. It is created by eHealthMe based on reports of 208,196 people who have side effects when taking Lasix from the FDA, and is updated regularly.

What is Lasix?

Lasix has active ingredients of furosemide. It is often used in swelling. eHealthMe is studying from 210,439 Lasix users. Check the latest studies of Lasix.

What is Haematological malignancy?

Haematological malignancy (cancer that affect blood, bone marrow, and lymph nodes) is found to be associated with 75 drugs and 351 conditions by eHealthMe. Check the latest studies of Haematological malignancy.



On Jul, 05, 2026

208,196 people reported to have side effects when taking Lasix.
Among them, 13 people (0.01%) have Haematological malignancy.

Could Lasix cause Haematological malignancy?

Among these 13 people:

What is the gender of people who have Haematological malignancy when taking Lasix? *

  • female: 66.67 %
  • male: 33.33 %

What is the age of people who have Haematological malignancy when taking Lasix? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 16.67 %
  • 60+: 75.0 %

What are other drugs people take besides Lasix? *

  1. Aldactone: 5 people, 38.46%
  2. Prednisone: 5 people, 38.46%
  3. Lisinopril: 4 people, 30.77%
  4. Coreg Cr: 3 people, 23.08%
  5. Lumigan: 3 people, 23.08%
  6. Norco: 3 people, 23.08%
  7. Nplate: 3 people, 23.08%
  8. Imdur: 3 people, 23.08%
  9. Prilosec: 3 people, 23.08%
  10. Zoloft: 3 people, 23.08%

What are other side effects people have besides Haematological malignancy? *

  1. Weight Decreased: 5 people, 38.46%
  2. Malaise (a feeling of general discomfort or uneasiness): 5 people, 38.46%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 38.46%
  4. Dyspnea (difficult or laboured breathing): 5 people, 38.46%
  5. Fall: 5 people, 38.46%
  6. Fatigue (feeling of tiredness): 5 people, 38.46%
  7. Haemorrhage (bleeding): 5 people, 38.46%
  8. Abdominal Distension: 5 people, 38.46%
  9. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 30.77%
  10. Taste - Impaired: 3 people, 23.08%

What are the existing conditions these people have? *

  1. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 5 people, 38.46%
  2. Cardiac Failure Congestive: 3 people, 23.08%
  3. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 15.38%
  4. High Blood Cholesterol: 2 people, 15.38%
  5. Cardiac Disorder: 2 people, 15.38%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
  7. Rashes (redness): 1 person, 7.69%
  8. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%
  9. Prostate Cancer Metastatic: 1 person, 7.69%
  10. Prostate Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lasix and have Haematological malignancy?

- Check whether Haematological malignancy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lasix:

  • Lasix (210,439 reports)

Haematological malignancy treatments and more:

How severe was Haematological malignancy and when was it recovered:

Expand to all the drugs that have ingredients of furosemide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lasix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematological malignancy:

Browse all the conditions that are associated with Haematological malignancy:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Lasix) and Lasix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: